Biogen a favorite stock

It seems Biogen 's stock trades with a discount.The majority of the analysts thinks Biogen is currently underpriced. Currently the company is being followed by 15 analyst. The recommendations for the stock contain no sells, 9 times hold and no buys. The average of the current target prices for the stock equals 349,14 USD. This is at around 22 percent more than the current price of 294,4 USD. The most recent recommendations for the biotech company are from Robert W. Baird, Oppenheimer & Co and Leerink Swann & Company.

Estimates for Biogen wide spread

Biogen 's market capitalization is based on the number of outstanding shares around 63,56 billion USD.

Historical stock prices Biogen

On Wednesday the stock closed at 294,4 USD.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.